Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > TCDAQ TRICIDA INC > Detailed Quotes

TCDAQ TRICIDA INC

Watchlist
0.0440.0000.00%
Close  02/01 16:00 ET
High
0.050
Open
0.044
Turnover
51.92K
Low
0.040
Pre Close
0.044
Volume
1.20M
Market Cap
2.55M
P/E(TTM)
Loss
52wk High
13.850
Shares
58.03M
P/E(Static)
Loss
52wk Low
0.040
Float Cap
1.47M
Bid/Ask %
0.00%
Historical High
44.300
Shs Float
33.59M
Volume Ratio
0.32
Historical Low
0.040
Dividend TTM
--
Div Yield TTM
--
P/B
-0.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.58%
Amplitude
22.02%
Avg Price
0.043
Lot Size
1
Float Cap
1.47M
Bid/Ask %
0.00%
Historical High
44.300
Shs Float
33.59M
Volume Ratio
0.32
Historical Low
0.040
Dividend TTM
--
P/B
-0.02
Dividend LFY
--
Turnover Ratio
3.58%
Amplitude
22.02%
Avg Price
0.043
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.
CEO: Dr. Gerrit Klaerner, PhD.
Market: Pink Market
Listing Date: 06/28/2018
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist